SLR Investment SLRC Q1 2026 Earnings Miss Sparks Concern Core Inflation Hits 32 as Q1 GDP Growth Disappoints Posing Challenges for Fed A Major AI IPO Hits the Market Today Amid Surging Tech Sector Momentum Longevity Biotech Stocks Rally as 27 Trillion Healthcare Transformation Accelerates Cell Restoration Focus Labor Market in Focus What the April Jobs Report Signals for the US Economy SWX Q1 2026 Earnings EPS Misses Estimates as Utility Faces Margin Pressures i2Cools ElectricityFree Cooling Film Deployed at Dorsett Putrajaya to Enhance Comfort and Energy Efficiency in LakeView Dining Amesite AMST Up 1214 Is There More Room to Run 20260520 Michael Price Advocates Contrarian Approach to Navigate Market Volatility Musical and Theatre Stars on Chasing Dreams and SelfImprovement Industry Insights European Telecoms CEO Warns of US Satellite and AI Dominance Risk Japans Megabanks Post Record Profits But Analysts Flag Headwinds Ahead Memorial Day 2026 Stock Market Closure and Holiday Trading Schedule Yardeni Warns Fed May Need to Raise Rates in July to Appease Bond Vigilantes VNCE Q1 2026 Earnings Massive EPS Beat Surprises Market Despite Revenue Gap SIGA Q1 2026 Earnings Net Loss of 005 per Share as Revenue Figures Remain Undisclosed NPCE Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Discipline SMMT Q1 2026 Earnings EPS Misses Street Expectations While Pipeline Momentum Continues Drilling Tools International DTI Q1 2026 Earnings EPS Misses Estimates Stock Declines David Miliband Urges National Consensus on EU Rejoining as UK Officials Propose Single Market for Goods ZBIO Q1 2026 Earnings NarrowerThanExpected Loss Caps a Quarter of Pipeline Progress Vine Hill VHCP Trading at 995 Key Decision Point 20260514 Ukraine Attacks Escalate Geopolitical Risk Global Markets Weigh SafeHaven Shifts Diamondrock DRH Slides 195 as Selling Pressure Mounts 20260515 Fed May Need to Raise Rates in July to Appease Bond Vigilantes Yardeni Warns VEON Ltd VEON Q1 2026 Earnings Surprise EPS 139 Up Significant TrumpRx Expands Discount Drug Offerings What Consumers Need to Know Yiren YRD Q2 2025 In Line Whats Next for Investors